ADIL — ADIAL PHARMACEUTICALS INC
As of Q2 2026, 6 SEC-registered investment managers reported holding ADIL (ADIAL PHARMACEUTICALS INC) in their latest 13F filings, with a combined reported value of $157.30K across 61.45K shares. That is +136.7% by share count (+35.49K shares) versus the previous quarter, while reported value moved +238.6%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.
Compared with the prior quarter, 1 opened new positions, 1 added to existing stakes, 2 trimmed. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q2 2026, not real-time trading.
ADIL is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
| Fund | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
| Citadel Advisors history | Q2 2026 | 29.55K | $75.64K | 0.00% | New |
| Goldman Sachs Group history | Q4 2021 | 19.53K | $53.00K | 0.00% | New |
| Millennium Management history | Q2 2022 | 39.49K | $53.00K | 0.00% | New |
| UBS Group AG history | Q2 2026 | 19.15K | $49.02K | 0.00% | Add |
| Renaissance Technologies history | Q4 2024 | 47.61K | $48.09K | 0.00% | New |
| Vanguard Group history | Q4 2025 | 156.02K | $34.33K | 0.00% | Hold |
| Geode Capital Management history | Q2 2026 | 12.39K | $31.73K | 0.00% | Reduce |
| Charles Schwab Investment Management history | Q2 2022 | 21.44K | $29.00K | 0.00% | New |
| Northern Trust Corp history | Q4 2025 | 65.98K | $14.52K | 0.00% | New |
| JPMorgan Chase & Co history | Q4 2023 | 2.50K | $4.65K | 0.00% | New |
| Two Sigma Investments history | Q2 2025 | 10.80K | $3.26K | 0.00% | New |
| BlackRock Inc history | Q2 2026 | 304 | $778 | 0.00% | Reduce |
| Morgan Stanley history | Q2 2026 | 50 | $128 | 0.00% | Hold |
| Bank of America Corp history | Q4 2025 | 205 | $45 | 0.00% | Add |
| Wells Fargo & Co history | Q2 2026 | 6 | $15 | 0.00% | Hold |
| Citigroup Inc history | Q4 2025 | 1 | $0 | — | New |
| Fidelity Management & Research (FMR) history | Q3 2022 | 7 | $0 | — | New |
New Positions (Q2 2026)
- Citadel Advisors 29.55K sh · $75.64K
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 17 funds)
| Fund | Q3 2021 | Q4 2021 | Q1 2022 | Q2 2022 | Q3 2022 | Q4 2022 | Q1 2023 | Q2 2023 | Q3 2023 | Q4 2023 | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Citadel Advisors | — | 38.90K | — | 21.10K | 265.06K | — | — | — | — | — | — | 24.75K | 33.27K | 54.51K | — | — | 143.79K | 219.62K | — | 29.55K |
| UBS Group AG | 4.39K | 3.62K | 6.84K | — | 35.52K | 22.05K | 10.63K | — | 546 | 3.62K | 5.73K | 83.61K | 4.40K | 21.02K | 47.74K | 12.39K | 18.76K | 9.17K | 542 | 19.15K |
| Geode Capital Management | 96.08K | 129.33K | 135.10K | 135.89K | 137.46K | 137.46K | 137.46K | 137.46K | — | — | — | 25.87K | 45.47K | 61.85K | 68.85K | 68.85K | 164.13K | 155.75K | 24.25K | 12.39K |
| BlackRock Inc | — | — | — | — | — | — | — | — | — | — | — | — | 27.77K | 27.77K | 27.77K | 27.77K | 27.77K | 27.77K | 1.11K | 304 |
| Morgan Stanley | 40.23K | 538 | 535 | 535 | 1.02K | 577 | 535 | 535 | 21 | 9 | 15 | 39 | 309 | 9 | 9 | 9 | 9 | 9 | 50 | 50 |
| Wells Fargo & Co | 865 | 865 | 968 | 996 | 1.00K | 916 | 919 | 187 | 8 | 8 | 11 | — | — | 160 | 160 | 160 | 160 | 160 | 6 | 6 |
| Bank of America Corp | — | — | — | — | — | — | — | — | — | — | — | 689 | 52 | 52 | 55 | 73 | 182 | 205 | — | — |
| Citigroup Inc | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | 3.97K | — | 1 | — | — |
| Northern Trust Corp | 29.30K | 29.30K | 29.30K | 29.70K | 29.70K | 29.70K | 29.70K | 29.70K | — | — | — | — | — | — | — | — | — | 65.98K | — | — |
| Vanguard Group | 594.44K | 590.85K | 590.85K | 590.85K | 616.86K | 478.88K | 203.36K | 203.36K | — | — | — | — | — | — | 13.16K | 13.16K | 156.02K | 156.02K | — | — |
| Fidelity Management & Research (FMR) | — | — | — | — | 7 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| JPMorgan Chase & Co | — | — | — | — | — | — | — | — | — | 2.50K | — | — | — | — | — | — | — | — | — | — |
| Goldman Sachs Group | — | 19.53K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Renaissance Technologies | — | — | 19.96K | 169.40K | 144.23K | 251.89K | 100.90K | 107.10K | — | 23.20K | 51.10K | 34.35K | — | 47.61K | — | — | — | — | — | — |
| Two Sigma Investments | — | — | — | — | 58.39K | 58.39K | 17.71K | 17.62K | — | — | — | — | — | — | — | 10.80K | — | — | — | — |
| Millennium Management | 17.05K | 20.75K | — | 39.49K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Charles Schwab Investment Management | 11.61K | 11.61K | — | 21.44K | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details